Literature DB >> 18058133

Identification and enzymatic activities of four protein disulfide isomerase (PDI) isoforms of Leishmania amazonensis.

B X Hong1, L Soong.   

Abstract

Leishmania parasites primarily infect cells of macrophage lineage and can cause leishmaniasis in the skin, mucosal, and visceral organs, depending on both host- and parasite-derived factors. The protein disulfide isomerases (PDIs) are thiol-disulfide oxidoreductases that catalyze the formation, reduction, and isomerization of disulfide bonds of proteins in cells. Although four Leishmania PDI genes are functionally inferred from homology in the genome sequences, only two of them have been expressed as active proteins to date. The functional relationship among various PDI enzymes remains largely unclear. In this study, we expressed and partially characterized all four L. amazonensis PDIs encoding 52-, 47-, 40-, and 15-kDa proteins. Homology analysis showed that the sequence identity between L. amazonensis (New World) PDIs and their counterpart PDI sequences from L. major (Old World) ranged from 76% to 99%. Kinetic characterization indicated that while the 15-, 40-, and 47- kDa PDI proteins displayed both insulin isomerase and reductase activities, the 52-kDa protein had only isomerase activity with no detectable reductase activity. All four PDI proteins were recognized by sera from L. amazonensis-infected mice and were sensitive to inhibition by standard PDI inhibitors. This study describes the enzymatic activities of recombinant L. amazonensis PDIs and suggests a role for these proteins in parasite development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18058133      PMCID: PMC2745823          DOI: 10.1007/s00436-007-0784-4

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  42 in total

1.  A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity.

Authors:  Y Belkaid; S Mendez; R Lira; N Kadambi; G Milon; D Sacks
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

Review 2.  Macrophages, pathology and parasite persistence in experimental visceral leishmaniasis.

Authors:  Christian R Engwerda; Manabu Ato; Paul M Kaye
Journal:  Trends Parasitol       Date:  2004-11

3.  Molecular cloning and expression of Caenorhabditis elegans ERp57-homologue with transglutaminase activity.

Authors:  S Natsuka; R Takubo; R Seki; K Ikura
Journal:  J Biochem       Date:  2001-12       Impact factor: 3.387

Review 4.  Leishmaniasis: current status of vaccine development.

Authors:  E Handman
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

5.  Pathogenic role of B cells and antibodies in murine Leishmania amazonensis infection.

Authors:  Nanchaya Wanasen; Lijun Xin; Lynn Soong
Journal:  Int J Parasitol       Date:  2007-09-20       Impact factor: 3.981

6.  Kinetics and specificity of homogeneous protein disulphide-isomerase in protein disulphide isomerization and in thiol-protein-disulphide oxidoreduction.

Authors:  N Lambert; R B Freedman
Journal:  Biochem J       Date:  1983-07-01       Impact factor: 3.857

7.  Protective secretory immunoglobulin A antibodies in humans following oral immunization with Streptococcus mutans.

Authors:  R L Gregory; S J Filler
Journal:  Infect Immun       Date:  1987-10       Impact factor: 3.441

8.  Protein disulfide isomerase of Toxoplasma gondii is targeted by mucosal IgA antibodies in humans.

Authors:  Bob Meek; Jaap Willem Back; Vincent N A Klaren; Dave Speijer; Ron Peek
Journal:  FEBS Lett       Date:  2002-07-03       Impact factor: 4.124

Review 9.  Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease?

Authors:  Diane McMahon-Pratt; James Alexander
Journal:  Immunol Rev       Date:  2004-10       Impact factor: 12.988

10.  Identification of a disulfide isomerase protein of Leishmania major as a putative virulence factor.

Authors:  Y Ben Achour; M Chenik; H Louzir; K Dellagi
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

View more
  13 in total

1.  Leishmania major protein disulfide isomerase as a drug target: enzymatic and functional characterization.

Authors:  Noureddine Ben Khalaf; Géraldine De Muylder; Hechmi Louzir; James McKerrow; Mehdi Chenik
Journal:  Parasitol Res       Date:  2011-12-09       Impact factor: 2.289

2.  Molecular cloning, expression, and immunolocalization of protein disulfide isomerase in excretory-secretory products from Clonorchis sinensis.

Authors:  Yue Hu; Lisi Huang; Yan Huang; Lei He; Fan Zhang; Wenfang Li; Pei Liang; Ran Li; Jiufeng Sun; Xiaoyun Wang; Chi Liang; Xuerong Li; Xinbing Yu
Journal:  Parasitol Res       Date:  2012-04-27       Impact factor: 2.289

3.  Molecular characterization and immunolocalization of a protein disulfide isomerase from Angiostrongylus cantonensis.

Authors:  Qian Liu; Xiao Yang; Meichun Zhang; Lin Wang; Jing Liu; Jing Chen; Ai He; Zhuoya Li; Zhongdao Wu; Ximei Zhan
Journal:  Parasitol Res       Date:  2012-01-05       Impact factor: 2.289

4.  A second protein disulfide isomerase plays a protective role against nitrosative and nutritional stresses in Schizosaccharomyces pombe.

Authors:  Eun-Hye Lee; Dong-Hoon Hyun; Eun-Hee Park; Chang-Jin Lim
Journal:  Mol Biol Rep       Date:  2010-03-04       Impact factor: 2.316

5.  An immunoproteomic approach to identifying immunoreactive proteins in Leishmania infantum amastigotes using sera of dogs infected with canine visceral leishmaniasis.

Authors:  Sajad Rashidi; Zahra Mojtahedi; Bahador Shahriari; Kurosh Kalantar; Ghasem Ghalamfarsa; Mehdi Mohebali; Gholamreza Hatam
Journal:  Pathog Glob Health       Date:  2019-05-17       Impact factor: 2.894

Review 6.  Emerging therapeutic targets for treatment of leishmaniasis.

Authors:  Shyam Sundar; Bhawana Singh
Journal:  Expert Opin Ther Targets       Date:  2018-05-09       Impact factor: 6.902

Review 7.  Protein disulfide isomerase and host-pathogen interaction.

Authors:  Beatriz S Stolf; Ioannis Smyrnias; Lucia R Lopes; Alcione Vendramin; Hiro Goto; Francisco R M Laurindo; Ajay M Shah; Celio X C Santos
Journal:  ScientificWorldJournal       Date:  2011-10-18

8.  Identification and characterization of genes involved in leishmania pathogenesis: the potential for drug target selection.

Authors:  Robert Duncan; Sreenivas Gannavaram; Ranadhir Dey; Alain Debrabant; Ines Lakhal-Naouar; Hira L Nakhasi
Journal:  Mol Biol Int       Date:  2011-06-26

9.  Identification of proteins in promastigote and amastigote-like Leishmania using an immunoproteomic approach.

Authors:  Vinicio T S Coelho; Jamil S Oliveira; Diogo G Valadares; Miguel A Chávez-Fumagalli; Mariana C Duarte; Paula S Lage; Manuel Soto; Marcelo M Santoro; Carlos A P Tavares; Ana Paula Fernandes; Eduardo A F Coelho
Journal:  PLoS Negl Trop Dis       Date:  2012-01-17

10.  The protein disulfide isomerase 1 of Phytophthora parasitica (PpPDI1) is associated with the haustoria-like structures and contributes to plant infection.

Authors:  Yuling Meng; Qiang Zhang; Meixiang Zhang; Biao Gu; Guiyan Huang; Qinhu Wang; Weixing Shan
Journal:  Front Plant Sci       Date:  2015-08-18       Impact factor: 5.753

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.